JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2004; 44:1570-1577, doi:10.1016/j.jacc.2004.07.028
© 2004 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Palmerini, T.
Right arrow Articles by Branzi, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Palmerini, T.
Right arrow Articles by Branzi, A.

Monocyte-derived tissue factor contributes to stent thrombosis in an in vitro system

Tullio Palmerini, MD*,*, Barry S. Coller, MD{ddagger}, Vittorio Cervi, BSc*, Luciana Tomasi, BSc*, Antonio Marzocchi, MD*, Cinzia Marrozzini, MD*, Ornella Leone, MD{dagger}, Milena Piccioli, BSC{dagger} and Angelo Branzi, MD*

* Istituto di Cardiologia
{dagger} Istituto di Anatomia Patologica, Policlinico S. Orsola, University of Bologna, Bologna, Italy
{ddagger} Laboratory of Blood and Vascular Biology, Rockefeller University, New York, New York



View larger version (159K):

[in a new window]
 
Figure 1 Thrombus formation after 120 min perfusion on stent surface exposed to blood pretreated with either saline (control) or with a monoclonal antibody against tissue factor (cH36). Note the striking reduction of thrombus formation on the stent in which blood was pretreated with cH36.

 


View larger version (124K):

[in a new window]
 
Figure 2 Histologic assessment of thrombi formed on a stent surface showing intense tissue factor staining (red). Monocytes (arrows) found in the thrombus displayed strong tissue factor staining, while granulocytes displayed weak and irregular staining. Original magnification 400x.

 


View larger version (37K):

[in a new window]
 
Figure 3 Tissue factor (TF) expression on monocyte membranes at baseline (A) and at the end of the perfusion (B). In two experiments monocytes were subjected to two-color analysis using TF-FITC as the abscissa and CD42b-PE as the ordinate: at baseline (C) there are some platelet-monocyte aggregates that do not display TF staining. At the end of the perfusion (D) only monocytes with attached platelets displayed TF staining.

 


View larger version (30K):

[in a new window]
 
Figure 4 Whole blood before (A) and after (B) anti-CD14 bead addition. Note in B the dramatic reduction of monocyte count. In controls that were subjected to all of the procedures used to deplete monocytes except for adding the anti-CD14-coupled beads, no difference was noticed between the baseline sample (C) and the sample after the procedures (D).

 


View larger version (98K):

[in a new window]
 
Figure 5 Immunohistochemistry of thrombi formed on stents perfused with whole blood (A) or monocyte-depleted blood (B). In B a strong reduction in tissue factor staining (red) was observed compared with A. Original magnification 200x.

 





HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2004 by the American College of Cardiology Foundation.